These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 9421280)

  • 21. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.
    Lähdesmäki J; Sallinen J; MacDonald E; Scheinin M
    Neuropsychopharmacology; 2004 Jul; 29(7):1282-93. PubMed ID: 15039766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The contribution of alpha-1 and alpha-2 adrenoceptors in peripheral imidazoline and adrenoceptor agonist-induced nociception.
    Dogrul A; Coskun I; Uzbay T
    Anesth Analg; 2006 Aug; 103(2):471-7, table of contents. PubMed ID: 16861437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
    Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice.
    Altman JD; Trendelenburg AU; MacMillan L; Bernstein D; Limbird L; Starke K; Kobilka BK; Hein L
    Mol Pharmacol; 1999 Jul; 56(1):154-61. PubMed ID: 10385696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advantageous safety profile of a dual selective alpha(2C) agonist/alpha(2A) antagonist antinociceptive agent.
    Delaunois A; De Ron P; Dedoncker P; Rosseels ML; Cornet M; Jnoff E; Hanon E; Guyaux M; Depelchin BO
    Fundam Clin Pharmacol; 2014 Aug; 28(4):423-38. PubMed ID: 24020399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables.
    Tufanogullari B; White PF; Peixoto MP; Kianpour D; Lacour T; Griffin J; Skrivanek G; Macaluso A; Shah M; Provost DA
    Anesth Analg; 2008 Jun; 106(6):1741-8. PubMed ID: 18499604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of alpha 2-adrenoceptor-mediated responses in pig nasal mucosa.
    Corboz MR; Varty LM; Rizzo CA; Mutter JC; Rivelli MA; Wan Y; Umland S; Qiu H; Jakway J; McCormick KD; Berlin M; Hey JA
    Auton Autacoid Pharmacol; 2003 Aug; 23(4):208-19. PubMed ID: 15084187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype.
    Sallinen J; Haapalinna A; Viitamaa T; Kobilka BK; Scheinin M
    Neuroscience; 1998 Oct; 86(3):959-65. PubMed ID: 9692731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
    Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1993 Feb; 264(2):762-9. PubMed ID: 8094751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between body temperature and dexmedetomidine-induced minimum alveolar concentration and respiratory changes in isoflurane-anesthetized miniature swine.
    Vainio OM; Bloor BC
    Am J Vet Res; 1994 Jul; 55(7):1000-6. PubMed ID: 7978616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype.
    Lähdesmäki J; Sallinen J; MacDonald E; Sirviö J; Scheinin M
    Neuropharmacology; 2003 Jun; 44(7):882-92. PubMed ID: 12726820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain.
    Guneli E; Karabay Yavasoglu NU; Apaydin S; Uyar M; Uyar M
    Pharmacol Biochem Behav; 2007 Nov; 88(1):9-17. PubMed ID: 17651791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α2C-adrenoceptor modulators: a patent review.
    Quaglia W; Del Bello F; Giannella M; Piergentili A; Pigini M
    Expert Opin Ther Pat; 2011 Apr; 21(4):455-81. PubMed ID: 21413828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist.
    Sallinen J; Link RE; Haapalinna A; Viitamaa T; Kulatunga M; Sjöholm B; Macdonald E; Pelto-Huikko M; Leino T; Barsh GS; Kobilka BK; Scheinin M
    Mol Pharmacol; 1997 Jan; 51(1):36-46. PubMed ID: 9016344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
    Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
    Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand-induced alpha2-adrenoceptor endocytosis: relationship to Gi protein activation.
    Olli-Lähdesmäki T; Tiger M; Vainio M; Scheinin M; Kallio J
    Biochem Biophys Res Commun; 2004 Aug; 321(1):226-33. PubMed ID: 15358239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin.
    Dekeyne A; Millan MJ
    Neuropharmacology; 2006 Sep; 51(4):718-26. PubMed ID: 16814817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice.
    Scheibner J; Trendelenburg AU; Hein L; Starke K
    Br J Pharmacol; 2001 Feb; 132(4):925-33. PubMed ID: 11181434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the alpha2C-adrenoceptor as a neuropsychiatric drug target studies in transgenic mouse models.
    Scheinin M; Sallinen J; Haapalinna A
    Life Sci; 2001 Apr; 68(19-20):2277-85. PubMed ID: 11358337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.